Novartis Venture Fund Parent: Novartis
Novartis Venture Fund (NVF) is a stage-agnostic venture arm of Novartis, engaging in investments from seed- to later-stage life sciences companies across Biotechnology/Biopharma, Medical Devices, and Diagnostics. Its primary focus is on the development of novel therapeutics and platforms, with a preference to either lead or co-lead an investment and play an active role on company boards. NVF's portfolio companies span North America, Europe, Israel, and Asia/Pacific.
Founded 1996
Employees 10+
Primary contact
Novartis International AG, P.O. Box
4002 Basel
Switzerland
Novartis International AG, P.O. Box
4002 Basel
Switzerland
Links
http://www.nvfund.com/
http://www.nvfund.com/
Key people 🧑🤝🧑
- Dr. Anja König - Global Head
- Dr. Laura Brass - Managing Director in Cambridge, MA
- Bart Dzikowski - Managing Director & Head of Transactions & Legal
- Dr. Florian Muellershausen - Managing Director in Basel, Switzerland
- Dr. Aaron Nelson - Managing Director in Cambridge, MA
- Dr. Nandita Shangari - Managing Director in Cambridge, MA
- Dr. Beat Steffen - Managing Director in Basel, Switzerland
- Dr. Marianne Uteng - Principal
Investments 💸
Developer of cancer treatments that target DNA Damage Response pathways to selectively kill cancer cells
📍 Cambridge, United Kingdom
Biotech company exploiting Protein Splicing to develop the next generation of gene therapies
📍 Barcelona, Spain
Developer of click-cleavable ADC therapies for patients suffering from severe diseases, including cancer
📍 Nijmegen, Netherlands
Last update: November 1, 2022
Disclaimer: We can not guarantee that the information on this page is 100% correct. more